For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
Independent Director and former CEO, Hillrom
Mr. Groetelaars brings more than 30 years of global leadership experience across a broad range of medical device sectors. Most recently he was interim CEO for Dentsply Sirona (Nasdaq: XRAY), having previously served in a director role for the company. Prior to Dentsply Sirona Mr. Groetelaars was President & CEO at Hillrom from May 2018 until the company’s acquisition by Baxter International, Inc. in 2021. At Hillrom, Mr. Groetelaars provided global leadership for a healthcare technology company with $3 billion in revenue and 10,000+ employees. Prior to joining Hillrom, Mr. Groetelaars served as executive vice president and president of the Interventional Segment at Becton, Dickinson and Company (BD) following its acquisition of C.R. Bard in December 2017. Earlier in his career, Mr. Groetelaars held various international leadership positions at Boston Scientific Corporation in Canada, Denmark and the UK as well as with Guidant Corporation and Eli Lilly. He earned his bachelor’s degree in Mechanical Engineering from Kettering University in Michigan and an MBA from Columbia University in New York.
BOARD OF DIRECTORS